OTCMKTS:IVITF

Invictus MD Strategies Competitors

$0.04
-0.01 (-21.28 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.04
Now: $0.04
$0.05
50-Day Range
$0.04
MA: $0.05
$0.07
52-Week Range
$0.00
Now: $0.04
$0.12
Volume46,100 shs
Average Volume135,837 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Invictus MD Strategies (OTCMKTS:IVITF) Vs. ABAHF, ACRGF, APPB, AYRSF, CANB, and CNTMF

Should you be buying IVITF stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Invictus MD Strategies, including Abacus Health Products (ABAHF), Acreage (ACRGF), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Can B (CANB), and Cansortium (CNTMF).

Abacus Health Products (OTCMKTS:ABAHF) and Invictus MD Strategies (OTCMKTS:IVITF) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, risk, earnings, profitability, valuation and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Abacus Health Products and Invictus MD Strategies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Abacus Health Products0000N/A
Invictus MD Strategies0000N/A

Profitability

This table compares Abacus Health Products and Invictus MD Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Abacus Health ProductsN/AN/AN/A
Invictus MD StrategiesN/AN/AN/A

Earnings & Valuation

This table compares Abacus Health Products and Invictus MD Strategies' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abacus Health ProductsN/AN/AN/AN/AN/A
Invictus MD StrategiesN/AN/AN/AN/AN/A

Acreage (OTCMKTS:ACRGF) and Invictus MD Strategies (OTCMKTS:IVITF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation and Earnings

This table compares Acreage and Invictus MD Strategies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AcreageN/AN/AN/AN/AN/A
Invictus MD StrategiesN/AN/AN/AN/AN/A

Profitability

This table compares Acreage and Invictus MD Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AcreageN/AN/AN/A
Invictus MD StrategiesN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations for Acreage and Invictus MD Strategies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Acreage01202.67
Invictus MD Strategies0000N/A

Acreage presently has a consensus target price of $8.4333, indicating a potential upside of 204.45%. Given Acreage's higher probable upside, equities research analysts clearly believe Acreage is more favorable than Invictus MD Strategies.

Summary

Acreage beats Invictus MD Strategies on 2 of the 2 factors compared between the two stocks.

Applied Biosciences (OTCMKTS:APPB) and Invictus MD Strategies (OTCMKTS:IVITF) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent recommendations for Applied Biosciences and Invictus MD Strategies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Applied Biosciences0000N/A
Invictus MD Strategies0000N/A

Valuation and Earnings

This table compares Applied Biosciences and Invictus MD Strategies' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Applied BiosciencesN/AN/AN/AN/AN/A
Invictus MD StrategiesN/AN/AN/AN/AN/A

Profitability

This table compares Applied Biosciences and Invictus MD Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Applied BiosciencesN/AN/AN/A
Invictus MD StrategiesN/AN/AN/A

Invictus MD Strategies (OTCMKTS:IVITF) and Ayr Strategies (OTCMKTS:AYRSF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Earnings & Valuation

This table compares Invictus MD Strategies and Ayr Strategies' top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invictus MD StrategiesN/AN/AN/AN/AN/A
Ayr StrategiesN/AN/AN/AN/AN/A

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Invictus MD Strategies and Ayr Strategies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invictus MD Strategies0000N/A
Ayr Strategies01602.86

Ayr Strategies has a consensus target price of $34.8571, indicating a potential upside of 63.96%. Given Ayr Strategies' higher probable upside, analysts plainly believe Ayr Strategies is more favorable than Invictus MD Strategies.

Profitability

This table compares Invictus MD Strategies and Ayr Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invictus MD StrategiesN/AN/AN/A
Ayr StrategiesN/AN/AN/A

Summary

Ayr Strategies beats Invictus MD Strategies on 2 of the 2 factors compared between the two stocks.

Invictus MD Strategies (OTCMKTS:IVITF) and Can B (NASDAQ:CANB) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

Earnings and Valuation

This table compares Invictus MD Strategies and Can B's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Invictus MD StrategiesN/AN/AN/AN/AN/A
Can BN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Invictus MD Strategies and Can B, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Invictus MD Strategies0000N/A
Can B0000N/A

Profitability

This table compares Invictus MD Strategies and Can B's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Invictus MD StrategiesN/AN/AN/A
Can BN/AN/AN/A

Cansortium (OTCMKTS:CNTMF) and Invictus MD Strategies (OTCMKTS:IVITF) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, profitability, earnings, institutional ownership and dividends.

Earnings & Valuation

This table compares Cansortium and Invictus MD Strategies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CansortiumN/AN/AN/AN/AN/A
Invictus MD StrategiesN/AN/AN/AN/AN/A

Profitability

This table compares Cansortium and Invictus MD Strategies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CansortiumN/AN/AN/A
Invictus MD StrategiesN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings and price targets for Cansortium and Invictus MD Strategies, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cansortium00103.00
Invictus MD Strategies0000N/A

Cansortium currently has a consensus price target of $1.20, indicating a potential upside of 43.13%. Given Cansortium's higher probable upside, research analysts clearly believe Cansortium is more favorable than Invictus MD Strategies.

Summary

Cansortium beats Invictus MD Strategies on 2 of the 2 factors compared between the two stocks.


Invictus MD Strategies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
ABAHF
Abacus Health Products
0.4$4.84-5.4%$0.00N/A0.00Gap Up
Acreage logo
ACRGF
Acreage
1.2$2.77-0.0%$0.00N/A0.00
APPB
Applied Biosciences
0.5$0.25-0.0%$0.00N/A0.00High Trading Volume
Increase in Short Interest
Gap Up
AYRSF
Ayr Strategies
1.4$21.26-0.0%$0.00N/A0.00
Can B logo
CANB
Can B
0.4$0.56-1.8%$0.00N/A0.00Gap Up
Cansortium logo
CNTMF
Cansortium
1.1$0.84-1.2%$0.00N/A0.00Decrease in Short Interest
Charlotte's Web logo
CWBHF
Charlotte's Web
1.3$4.30-4.9%$0.00N/A0.00
Choom logo
CHOOF
Choom
0.5$0.10-0.0%$0.00N/A0.00Decrease in Short Interest
Gap Up
CPHRF
Cipher Pharmaceuticals
1.2$1.08-0.0%$0.00N/A0.00Decrease in Short Interest
CLS Holdings USA logo
CLSH
CLS Holdings USA
0.7$0.22-0.0%$0.00N/A0.00Gap Down
Cosmos logo
COSM
Cosmos
0.5$5.70-1.8%$0.00N/A0.00Increase in Short Interest
Gap Up
Cresco Labs logo
CRLBF
Cresco Labs
1.5$12.48-2.0%$0.00N/A0.00
Curaleaf logo
CURLF
Curaleaf
1.6$14.42-1.9%$0.00N/A0.00
HMDEF
DionyMed Brands
0.5N/AN/A$0.00N/A0.00High Trading Volume
Easton Pharmaceuticals logo
EAPH
Easton Pharmaceuticals
0.5$0.00-0.0%$0.00N/A0.00Decrease in Short Interest
Gap Down
Elixinol Global logo
ELLXF
Elixinol Global
0.8$0.15-0.0%$0.00N/A0.00Increase in Short Interest
Gap Down
EVIO
EVIO
0.6$0.00-0.0%$0.00N/A0.00Increase in Short Interest
Gap Down
Flower One logo
FLOOF
Flower One
0.4$0.28-0.0%$0.00N/A0.00Decrease in Short Interest
Gap Up
Golden Leaf logo
GLDFF
Golden Leaf
0.5$0.05-0.0%$0.00N/A0.00Decrease in Short Interest
Gap Down
Green Growth Brands logo
GGBXF
Green Growth Brands
0.4$0.01-0.0%$0.00N/A0.00Gap Down
Green Thumb Industries logo
GTBIF
Green Thumb Industries
1.7$28.53-1.5%$0.00N/A0.00Gap Up
GTEC logo
GGTTF
GTEC
0.6$0.61-1.6%$0.00N/A0.00Increase in Short Interest
News Coverage
Gap Down
Harvest Health & Recreation logo
HRVSF
Harvest Health & Recreation
1.3$2.92-4.8%$0.00N/A0.00
Hemp Naturals logo
HPMM
Hemp Naturals
0.6$0.01-0.0%$0.00N/A0.00Decrease in Short Interest
Hexo logo
HYYDF
Hexo
0.6$5.30-1.8%$0.00N/A0.00
Hikma Pharmaceuticals logo
HKMPY
Hikma Pharmaceuticals
0.4$59.68-0.0%$0.00N/A0.00
iAnthus Capital logo
ITHUF
iAnthus Capital
0.6$0.23-4.4%$0.00N/A0.00News Coverage
Gap Up
Icanic Brands logo
ICNAF
Icanic Brands
0.6$0.34-2.9%$0.00N/A0.00Decrease in Short Interest
News Coverage
KNHBF
ICC International Cannabis
0.6N/AN/A$0.00N/A0.00
Isodiol International logo
ISOLF
Isodiol International
0.4$0.05-44.4%$0.00N/A0.00Gap Down
Khiron Life Sciences logo
KHRNF
Khiron Life Sciences
1.4$0.43-4.7%$0.00N/A0.00Decrease in Short Interest
News Coverage
KHTRF
Knight Therapeutics
1.2$4.20-0.5%$0.00N/A0.00
Marijuana Company of America logo
MCOA
Marijuana Company of America
0.5$0.01-0.0%$0.00N/A0.00Increase in Short Interest
Gap Up
Medical Marijuana logo
MJNA
Medical Marijuana
0.6$0.05-0.0%$0.00N/A0.00
MediPharm Labs logo
MEDIF
MediPharm Labs
1.2$0.40-5.0%$0.00N/A0.00Increase in Short Interest
MedMen Enterprises logo
MMNFF
MedMen Enterprises
0.8$0.35-5.7%$0.00N/A0.00Increase in Short Interest
Gap Down
MERCK Kommanditgesellschaft auf Aktien logo
MKKGY
MERCK Kommanditgesellschaft auf Aktien
0.5$34.83-1.4%$0.00N/A0.00Increase in Short Interest
MJardin Group logo
MJARF
MJardin Group
0.9$0.08-12.0%$0.00N/A0.00Increase in Short Interest
Gap Up
MYHI
Mountain High Acquisitions
0.5$0.03-33.3%$0.00N/A0.00Decrease in Short Interest
News Coverage
Gap Up
PHCEF
Pharmacielo
0.7$1.51-4.6%$0.00N/A0.00Gap Down
Plus Products logo
PLPRF
Plus Products
1.1$0.55-3.6%$0.00N/A0.00Decrease in Short Interest
Premier Biomedical logo
BIEI
Premier Biomedical
0.5$0.00-4.0%$0.00N/A0.00
PCYN
Procyon
0.4$0.70-0.0%$0.00N/A0.00
Pure Global Cannabis logo
PRCNF
Pure Global Cannabis
0.7$0.01-0.0%$0.00N/A0.00Decrease in Short Interest
Gap Up
SANP
Santo Mining
0.5$0.01-0.0%$0.00N/A0.00Gap Down
Shionogi & Co., Ltd. logo
SGIOY
Shionogi & Co., Ltd.
0.5$13.18-1.6%$0.00N/A0.00Increase in Short Interest
DNPUF
Sumitomo Dainippon Pharma
0.5$17.40-0.0%$0.00N/A0.00News Coverage
TerrAscend logo
TRSSF
TerrAscend
1.7$9.80-3.2%$0.00N/A0.00Increase in Short Interest
The Flowr logo
FLWPF
The Flowr
1.5$0.25-4.0%$0.00N/A0.00Decrease in Short Interest
The Supreme Cannabis logo
SPRWF
The Supreme Cannabis
1.0$0.31-3.2%$0.00N/A0.00
This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.